You are here: Industry Insights > Endo

News List

Federal judge scolds Purdue, Endo and Mallinckrodt for stall tactics in opioids case fiercepharma
April 23, 2019
U.S. District Judge Dan Polster has had enough of opioids makers Purdue Pharma, Endo and Mallinckrodt asking for extensions in the multistate lawsuit against them.
Endo terminates $190M deal for sterile injectable player fiercepharma
March 03, 2019
The Dublin-based Endo and its Par sterile injectables subsidiaries Wednesday said a $190 million agreement to buy sterile injectables company Somerset Therapeutics had been terminated without penalties because it was taking too long to complete.
Endo turns to the produce aisle for G-rated visuals in new Peyronie's ad fiercepharma
January 23, 2019
Imagine having to talk about a disease that makes men's private parts curve unnaturally—without using the usual words—and you'll see why Endo's new Peyronie's ad might at first look like a vegetable commercial.
Curadev, Endo Pharma oncology program reaches milestone biospectrumasia
October 29, 2018
Curadev, Endo Pharma oncology program reaches milestone
AbbVie strikes tentative deal to settle 4,000-plus AndroGel lawsuits fiercepharma
September 12, 2018
Lawyers for AbbVie and AndroGel plaintiffs have reached a potential settlement, Judge Matthew Kennelly wrote in a Monday court filing.
Endo breaks from the pack with opioid litigation settlement talks fiercepharma
September 12, 2018
Endo Pharmaceuticals has been settling litigation for hundreds of millions of dollars while it works to cut its $8 billion in debt.
Endo, building on DTC success, ramps up awareness campaign for Peyronie’s disease fiercepharma
August 23, 2018
Endo Pharmaceuticals is continuing its awareness advertising push around conditions that can be treated with its injectable Xiaflex. (Pixabay/CC BY 2.0)
Endo granted injunction to block blood pressure competitor pharmafile
March 05, 2018
Endo International, a generic and specialty pharmaceutical company, has revealed that it has obtained a preliminary injunction to stop rival QuVa from selling its products
Struggling Endo's write-downs pass $5B for 2017 thanks to Opana, mesh, restructuring fiercepharma
August 09, 2017
In Feburary 2017, Endo took a huge $3.5 billion write-down—but that wouldn’t be just it for the year.
Endo to Restructure Manufacturing Network americanpharmaceuticalreview
July 24, 2017
Endo International announced that after completing a comprehensive review of its manufacturing network, the company will be ceasing operations and closing its manufacturing and distribution facilities in Huntsville, Alabama

Previous page 1 2 3 Next page